Similar Items: Investigating novel variants associated with the isoniazid resistance phenotype in MDR-TB using whole genome sequencing
- Determination of the mechanism of synergy of SQ109 with rifampicin and isoniazid in Mycobacterium smegmatis
- Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
- Overexpression of mmpS5/mmpL5 in Mycobacterium tuberculosis reduces susceptibility to anti-tuberculosis drugs
- Marine bacteria as sources of antimycobacterial agents
- Metallophiles as sources of antimycobacterial agents
- The pharmacokinetics and toxicity of antituberculosis agents and other co-administered drugs in children with tuberculosis, with and without HIV infection, and their relationship to nutritional status